Pain

Comprehend Systems Appoints New CEO in Response to Surging Demand for Clinical Intelligence Solutions; Enterprise Growth Expert to Scale Company and Expand Partner Ecosystem

November 20, 2017

Redwood City, Calif., November 13, 2017—Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, has named Terry Cunningham CEO.  Cunningham will focus on scaling Comprehend in response to explosive customer demand for solutions that reduce time and risk in clinical trials. Cunningham will also drive expanded partner programs to help sponsors achieve faster, better clinical […]

iX Biopharma Starts Off 1Q18 on Sound Note

November 8, 2017

Singapore, 8 November 2017 – Specialty pharmaceutical company iX Biopharma Ltd (“iX Biopharma” or “the Group”) has reported results for its first financial quarter ended 30 September 2017 (“1Q18”) that reflects progress made in the development of its pharmaceutical products and preparations for the upcoming launch of its new range of next-generation nutraceutical products. Year-on-year, […]

Indivior drug to fight opioid addiction recommended by U.S. panel

November 2, 2017

(Reuters) – Indivior’s experimental drug to help fight America’s growing opioid addiction crisis has been recommended for approval by a U.S. advisory panel, boosting its sales prospects as competitors threaten revenues from an older product.   Shares in the London-listed company, which specializes in addiction treatment, were 11 % higher by 0855 GMT on Wednesday […]

New Peer-Reviewed Study Finds Illegal Online Pharmacies are Using Twitter to Illegally Sell Percocet®, Fentanyl, Vicodin®, Oxycotin®, and Other Highly Addictive Opiods To U.S. Consumers

October 26, 2017

SAN DIEGO, CA (October 26, 2017) – Results from a new peer-reviewed study to be published in the November issue of American Journal of Public Health (AJPH) found illegal online pharmacies are using Twitter to market and sell Percocet®, Vicodin®, Oxycontin®, hydrocodone, fentanyl and oxycodone and other highly addictive and often deadly controlled substances to U.S. consumers, […]

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None

October 13, 2017

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None Every year for the past 30 years, Dr. Jurgensen has spent his vacations relieving the unimaginable suffering of impoverished people who have no access to dental care or hygiene. Newport Beach, Calif., October […]

New Research Published Describing an Innovative Concept for Treating Widespread Fibromyalgia Pain

June 30, 2017

SAN DIEGO, June 30, 2017 /PRNewswire/ — AVACEN Medical (AVACEN) announced the publication of new research in the peer-reviewed Fibromyalgia Open Access Journal. The research describes the use of its AVACEN Treatment Method to significantly reduce the widespread pain symptom experienced by those suffering from fibromyalgia. Fibromyalgia is characterized by chronic widespread pain. It affects […]

Do opioid drug-abuse deterrents actually work? FDA wants to know.

June 15, 2017

The Food and Drug Administration is ramping up scrutiny of anti-abuse features on opioid painkillers to try to determine if they actually do what they’re intended to do. On Tuesday, the agency announced a two-day public meeting that will focus on whether the agency has “the right information to determine whether these products are having […]

iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX

May 16, 2017

Singapore, 15 May 2017 – Homegrown specialty pharmaceutical company iX Biopharma Ltd. (“iX Biopharma” or, together with its subsidiaries, “the Group”) is pleased to announce the results of BUP001, a pharmacokinetic study of its novel sublingual buprenorphine wafer, BnoX. BnoX, which uses the Group’s patented sublingual drug delivery technology, WaferiX, is one of the Group’s […]

Worldwide Clinical Trials Expert To Present At The American Academy Of Pain Medicine Annual Meeting

March 20, 2017

MORRISVILLE, NC, March 17, 2017 – Miroslav Backonja, M.D., Senior Medical Director at Worldwide Clinical Trials (www.worldwide.com), will be presenting two sessions at the American Academy of Pain Medicine (AAPM) Annual Meeting, being held March 16-18, 2017 in Orlando, Florida. Now in its 33rd year, AAPM brings together clinicians, researchers, and educators in pain medicine […]

iX Biopharma 2Q17 Update on Drug Development

February 9, 2017

NEWS RELEASE 2Q17 UPDATE ON DRUG DEVELOPMENT Singapore, 8 February 2017 – For the financial quarter ended 31 December 2016 (“2Q17”), specialty pharmaceutical company iX Biopharma Ltd (“iX Biopharma” or, together with its subsidiaries, “the Group”) continued its preparations for the registration of two products with the Therapeutic Goods Administration (“TGA”) in Australia, and for […]

Men’s Health Exhibition and Conference 2017

December 5, 2016

We are pleased to have launched the first edition of Men’s Health Exhibition & Conference, the region’s leading congress for men’s healthcare on 15-16 October 2017 at the JW Marriott Marquis Hotel, Dubai, United Arab Emirates supported by the Ministry of Health, Emirates Medical Association, Emirates Urological Society, Dubai Health Authority and Dubai Healthcare City. […]

Kuwait Health Exhibition and Conference 2017

December 5, 2016

Kuwait Health Exhibition & Conference is the largest healthcare event in Kuwait on 6-8 March 2017 at the Kuwait International Fair, Kuwait. The event provides a business platform for the industry’s leading manufacturer, suppliers, distributors and service providers in the healthcare industry in one of MENA’s emerging market – Kuwait. The event will feature over […]

New Podcast and White Paper on the Pain Market

August 11, 2014

Podcast: Pharma Attempts to Ease the Pain Thought Leader: Michael Fronstin, General Manager, Health Outcomes, Forecasting and Epidemiology, Kantar Health In this episode, Mr. Fronstin illustrates the size and scope of the pain market, addresses current unmet needs, outlines promising new Mechanisms of Action, and covers the implications for the pharma industry. Michael Fronstin Play podcast […]

FEEDBACK